MS Awareness Month brings advocacy campaigns, educational events, and fundraisers as organizations spotlight resources for people with MS.

An energy boost following her breakup with coffee reminds columnist Susan Payrovi, MD. to focus on clean, renewable sources of energy.

Ocrevus (ocrelizumab) and Tysabri (natalizumab) appear equally effective at controlling relapses and MS progression, a study finds.

Having parents with a history of smoking is associated with a significantly increased risk of developing pediatric MS, a ...

Researchers mapped myelin-making cells in mice, showing some brain regions recover better after myelin damage.

For years, columnist Ben Hofmeister avoided talking about his invisible scars caused by the silent challenges of life with MS.

Merck and Mayo Clinic are partnering to use AI technology and large-scale clinical data to speed drug development in MS and ...

People with multiple sclerosis have a nearly fivefold increased risk of developing dementia compared with those without MS, a study found.

Bladder issues are a daily reality for many with MS, writes columnist Desiree Lama, who encourages more open discussion about the topic.

A new community-led network called PRADA enables underrepresented patients living with MS to help set research priorities.

Real-world data show Ocrevus reduced relapse rates and maintained disability stability in relapsing MS over four years.